Team analyses genetic and epicenetic regulators:

Infection with SARS-CoV-2 leads to severe disease in some people, whereas others do not get ill or only experience mild disease. But why is this the case? Unfortunately, we do not know exactly. We do know that an overactive innate immune system is causing severe COVID-19 disease, but it is unclear how this is regulated.

A team around Professor Dr. Yang Li, which includes numerous other RESIST researchers, has come a step closer to answering this question. They addressed the question to what extent the course of disease is genetically or epigenetically regulated.

The team was able to identify underlying regulators of the malfunction of the innate immune system in COVID-19 patients and confirm that certain already known genetic risk loci play a role in the development of the COVID-19 disease. The results have been published in the journal Cell Genomics. First authors on this publication are Dr. Valerie Koeken together with Dr. Bowen Zhang and Dr. Zhenhua Zhang. The research team conducted the study at the Centre for Individualised Infection Medicine (CiiM).

For this study, the team examined individual immune cells from the blood of COVID-19 patients using single-cell multiomics analysis. This technique can be used to simultaneously assess how cells are being regulated and how they are functioning. For this purpose, both the genetic material of the cells is examined and it is analysed if certain parts of the genome are ‘switched on’ (epigenetics) and if genes are being transcribed into ribonucleic acid molecules.

In a specific type of white blood cells (monocytes), which are overactivated in severe COVID-19 disease, they were able to identify how altered accessibility to chromatin is regulating gene expression and which transcription factors are steering these dysfunctional monocytes. In addition, they were able to identify how a specific genetic variant is contributing to both a higher viral load and an increased risk of needing hospitalisation for COVID-19. This enabled them to identify one of the factors driving increased susceptibility of severe disease in certain individuals. “Overall, our study highlights the multiple genetic and epigenetic regulators that contribute to COVID-19,” summarises Prof Li.

The photo shows Dr. Valerie Koeken, Dr. Zhenhua Zhang und Dr. Bowen Zhang (from left). © TWINCORE/Grabowski.